Litcius/Paper detail

Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the <i>MUC5B</i> Promoter Variant

Scott M. Matson, Kevin D. Deane, Anna L. Peljto, Tami J. Bang, Peter B. Sachs, Avram D. Walts, Christopher Collora, Shuyu Ye, M. Kristen Demoruelle, Stephen M. Humphries, David A. Schwartz, Joyce S. Lee

2021American Journal of Respiratory and Critical Care Medicine44 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInterstitial lung diseaseRheumatoid arthritisSubclinical infectionProspective cohort studyInternal medicineCohortRespiratory diseaseIdentification (biology)Cohort studyLung diseaseGastroenterologyDiseasePathologyImmunologyArthritisImmunopathologyLungRheumatoid factorComorbidityComplicationClinical diseaseSeverity of illnessOncologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisMycobacterium research and diagnosisPneumonia and Respiratory Infections
Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the <i>MUC5B</i> Promoter Variant | Litcius